首页 | 本学科首页   官方微博 | 高级检索  
     


Epigenome Microarray Platform for Proteome-Wide Dissection of Chromatin-Signaling Networks
Authors:Dennis J. Bua  Alex J. Kuo  Peggie Cheung  Chih Long Liu  Valentina Migliori  Alexsandra Espejo  Fabio Casadio  Christian Bassi  Bruno Amati  Mark T. Bedford  Ernesto Guccione  Or Gozani
Affiliation:1. Department of Biology, Stanford University, Stanford, California, United States of America.; 2. Institute of Molecular and Cell Biology, Singapore, Singapore.; 3. University of Texas M.D. Anderson Cancer Center, Smithville, Texas, United States of America.; 4. Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.;University of Munich and Center of Integrated Protein Science, Germany
Abstract:Knowledge of protein domains that function as the biological effectors for diverse post-translational modifications of histones is critical for understanding how nuclear and epigenetic programs are established. Indeed, mutations of chromatin effector domains found within several proteins are associated with multiple human pathologies, including cancer and immunodeficiency syndromes. To date, relatively few effector domains have been identified in comparison to the number of modifications present on histone and non-histone proteins. Here we describe the generation and application of human modified peptide microarrays as a platform for high-throughput discovery of chromatin effectors and for epitope-specificity analysis of antibodies commonly utilized in chromatin research. Screening with a library containing a majority of the Royal Family domains present in the human proteome led to the discovery of TDRD7, JMJ2C, and MPP8 as three new modified histone-binding proteins. Thus, we propose that peptide microarray methodologies are a powerful new tool for elucidating molecular interactions at chromatin.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号